September 30, 2024
Nostrum Laboratories, Inc.
Case Number:
2:24-bk-19611
Court:
Nature of Suit:
Firms
- Ansell Grimm
- Broege Neumann
- Buchalter APC
- Chiesa Shahinian
- Dembo Brown
- Fleischer Fleischer
- Greenbaum Rowe
- Greenberg Traurig
- Hogan Lovells
- Klehr Harrison
- Kurzman Eisenberg
- McManimon Scotland
- Norris McLaughlin
- Pashman Stein
- Porzio Bromberg
- Stark & Stark
- Stradley Ronon
- Togut Segal
Companies
- Ansell Ltd.
- Canon Financial Services Inc.
- Canon Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Enclara Pharmacia
- Humana Inc.
- McKesson Corp.
- Nostrum Laboratories Inc.
- Raymond James Financial Inc.
- Viatris Inc.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 22, 2025
Nostrum Cleared for $1.75M Sale Of Ohio Drug Facility
Bankrupt drugmaker Nostrum Laboratories received approval from a New Jersey court for a $1.75 million sale of an Ohio facility after reaching an agreement with the buyer and lenders over the costs of removing controlled substances at the property.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login